Okta has informed customers of a breach that occurred two months ago, where hackers stole user data from its customer support system. The breach allowed access to information that includes names and email addresses. While there is no current evidence of active exploitation, Okta has warned customers of potential phishing and social engineering risks.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
